Wednesday, January 25, 2006 1:32:42 AM
Wednesday January 11, 9:36 am ET
Mylan Laboratories Inc. has agreed to allow Cephalon Inc. to use its transdermal technology in two separate agreements aimed at developing treatments for pain and nervous system disorders...
Link to article:
http://biz.yahoo.com/bizj/060111/1213653.html?.v=1
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM